[1] R. A. Poldrack, J. A. Mumford, and T. E. Nichols, Handbook of functional MRI data analysis. Cambridge University Press, 2011.
[2] S. M. Smith and T. E. Nichols, “Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference,” NeuroImage, vol. 44, no. 1, pp. 83 – 98, 2009.
[3] M. Smith and L. Fahrmeir, “Spatial Bayesian variable selection with application to functional magnetic resonance imaging,” Journal of the American Statistical Association, vol. 102, no. 478, pp. 417–431, 2007.
[4] H. Shu, B. Nan, and R. Koeppe, “Multiple testing for neuroimaging via hidden Markov random field,” Biometrics, vol. 71, no. 3, pp. 741–750, 2015.
[5] W. Sun and T. T. Cai, “Large-scale multiple testing under dependence,” Journal of the Royal Statistical Society: Series B (Statistical Methodology), vol. 71, no. 2, pp. 393–424, 2009.
[6] D. A. Brown, N. A. Lazar, G. S. Datta, W. Jang, and J. E. McDowell, “Incorporating spatial dependence into Bayesian multiple testing of statistical parametric maps in functional neuroimaging,” NeuroImage, vol. 84, pp. 97–112, 2014.
[7] M. C. Reddan, M. A. Lindquist, and T. D. Wager, “Effect size estimation in neuroimaging,” JAMA Psychiatry, vol. 74, no. 3, pp. 207–208, 2017.
[8] M. A. Lindquist and A. Mejia, “Zen and the art of multiple comparisons,” Psychosomatic Medicine, vol. 77, no. 2, pp. 114–125, 2015.
[9] B. Efron, “Empirical Bayes estimates for large-scale prediction problems,” Journal of the American Statistical Association, vol. 104, no. 487, pp. 1015–1028, 2009.
[10] S. Matsui and H. Noma, “Estimating effect sizes of differentially expressed genes for power and sample-size assessments in microarray experiments,” Biometrics, vol. 67, no. 4, pp. 1225–1235, 2011.
[11] B. Efron, “Microarrays, empirical bayes and the two-groups model,” Statistical Science, vol. 23, no. 1, pp. 1–22, 2008.
[12] L. D. Brown, “Admissible estimators, recurrent diffusions, and insoluble boundary value problems,” The Annals of Mathematical Statistics, vol. 42, no. 3, pp. 855–903, 1971.
[13] C. M. Stein, “Estimation of the mean of a multivariate normal distribution,” The annals of Statistics, vol. 9, no. 6, pp. 1135–1151, 1981.
[14] W. Shen and T. A. Louis, “Empirical Bayes estimation via the smoothing by roughening approach,” Journal of Computational and Graphical Statistics, vol. 8, no. 4, pp. 800–823, 1999.
[15] S. Matsui and H. Noma, “Estimation and selection in high-dimensional genomic studies for developing molecular diagnostics,” Biostatistics, vol. 12, no. 2, pp. 223– 233, 2011.
[16] P. Mu ̈ller and R. Mitra, “Bayesian nonparametric inference–why and how,” Bayesian analysis, vol. 8, no. 2, 2013.
[17] B. Efron, Large-Scale Inference: Empirical Bayes Methods for Estimation, Testing, and Prediction. Institute of Mathematical Statistics Monographs, Leiden: Cambridge University Press, 2010.
[18] N. Tzourio-Mazoyer, B. Landeau, D. Papathanassiou, F. Crivello, O. Etard, N. Delcroix, B. Mazoyer, and M. Joliot, “Automated Anatomical Labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain,” NeuroImage, vol. 15, no. 1, pp. 273 – 289, 2002.
[19] Z. Wei, W. Sun, K. Wang, and H. Hakonarson, “Multiple testing in genome-wide association studies via hidden Markov models,” Bioinformatics, vol. 25, no. 21, pp. 2802–2808, 2009.
[20] D. S. Marcus, A. F. Fotenos, J. G. Csernansky, J. C. Morris, and R. L. Buckner, “Open Access Series of Imaging Studies: Longitudinal MRI data in nondemented and demented older adults,” Journal of Cognitive Neuroscience, vol. 22, no. 12, pp. 2677–2684, 2010.
[21] J. Ashburner, “A fast diffeomorphic image registration algorithm,” NeuroImage, vol. 38, no. 1, pp. 95 – 113, 2007.
[22] R. T. Shinohara, E. M. Sweeney, J. Goldsmith, N. Shiee, F. J. Mateen, P. A. Calabresi, S. Jarso, D. L. Pham, D. S. Reich, C. M. Crainiceanu, et al., “Statistical normalization techniques for magnetic resonance imaging,” NeuroImage: Clinical, vol. 6, pp. 9–19, 2014.
[23] Y. Deng, K. Liu, L. Shi, Y. Lei, P. Liang, K. Li, W. C. W. Chu, and D. Wang for the Alzheimer’s Disease Neuroimaging Initiative, “Identifying the alteration patterns of brain functional connectivity in progressive mild cognitive impairment patients: A longitudinal whole-brain voxel-wise degree analysis,” Frontiers in Aging Neuroscience, vol. 8, p. 195, 2016.
[24] P. J. Modrego, N. Fayed, and M. Sarasa, “Magnetic resonance spectroscopy in the prediction of early conversion from amnestic mild cognitive impairment to dementia: a prospective cohort study,” BMJ open, vol. 1, no. 1, 2011.
[25] E. Pravatà, J. Tavernier, R. Parker, H. Vavro, J. E. Mintzer, and M. V. Spampinato, “The neural correlates of anomia in the conversion from mild cognitive impairment to Alzheimer’s disease,” Neuroradiology, vol. 58, no. 1, pp. 59–67, 2016.
[26] S. F. Eskildsen, P. Coupé, V. S. Fonov, J. C. Pruessner, and D. L. Collins, “Structural imaging biomarkers of Alzheimer’s disease: predicting disease progression,” Neurobiology of Aging, vol. 36, pp. S23–S31, 2015.
[27] Y. Liu, T. Paajanen, Y. Zhang, E. Westman, L.-O. Wahlund, A. Simmons, C. Tunnard, T. Sobow, P. Mecocci, M. Tsolaki, B. Vellas, S. Muehlboeck, A. Evans, C. Spenger, S. Lovestone, and H. Soininen, “Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer’s disease,” Neurobiology of Aging, vol. 31, no. 8, pp. 1375–1385, 2010.
[28] X. Tang, D. Holland, A. M. Dale, L. Younes, M. I. Miller, and A. D. N. Initiative, “Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer’s disease: detecting, quantifying, and predicting,” Human Brain Mapping, vol. 35, no. 8, pp. 3701–3725, 2014.
[29] H.-A. Yi, C. Möller, N. Dieleman, F. H. Bouwman, F. Barkhof, P. Scheltens, W. M. van der Flier, and H. Vrenken, “Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer’s disease,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 87, no. 4, pp. 425–432, 2016.
[30] G. Karas, J. Sluimer, R. Goekoop, W. van der Flier, S. Rombouts, H. Vrenken, P. Scheltens, N. Fox, and F. Barkhof, “Amnestic mild cognitive impairment: Structural MR imaging findings predictive of conversion to Alzheimer disease,” American Journal of Neuroradiology, vol. 29, no. 5, pp. 944–949, 2008.
[31] T. Kato, Y. Inui, A. Nakamura, and K. Ito, “Brain fluorodeoxyglucose (FDG) PET in dementia,” Ageing research reviews, vol. 30, pp. 73–84, 2016.
[32] C. Salvatore, A. Cerasa, and I. Castiglioni, “MRI characterizes the progressive course of AD and predicts conversion to Alzheimer’s dementia 24 months before probable diagnosis,” Frontiers in Aging Neuroscience, vol. 10, p. 135, 2018.
[33] J. E. Desmond and G. H. Glover, “Estimating sample size in functional MRI (fMRI) neuroimaging studies: statistical power analyses,” Journal of Neuroscience Methods, vol. 118, no. 2, pp. 115 – 128, 2002.
[34] B. Efron, “Large-scale simultaneous hypothesis testing: the choice of a null hypoth- esis,” Journal of the American Statistical Association, vol. 99, no. 465, pp. 96–104, 2004.